Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of ...

Advancements in technology, rising respiratory disease prevalence, and a growing emphasis on home-based healthcare drive robust growth in the spirometer market.Pune, Jan. 21, 2025 (GLOBE NEWSWIRE) -- ...

AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...

It has been found in a recent study published in Heliyon that individuals who are genetically predisposed to having ...

Hospital-at-home initiatives use innovative technologies and sensors to deliver continuous care, improving patient quality of ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Learn how personalized exercise routines can transform your COPD journey, enhance resilience, and improve your quality of ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

The global durable medical equipment market size was valued at USD 232.33 billion in 2024 and is projected to grow from USD ...

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

Asthma diagnosis and monitoring device specialist Niox Group reported a solid end to its financial year on Thursday, ...